Nerve and Vascular Biomarkers in Skin Biopsies Differentiate Painful From Painless Peripheral Neuropathy in Type 2 Diabetes

被引:11
作者
Shillo, Pallai [1 ]
Yiangou, Yiangos [2 ]
Donatien, Philippe [2 ]
Greig, Marni [1 ]
Selvarajah, Dinesh [1 ]
Wilkinson, Iain D. [3 ]
Anand, Praveen [2 ]
Tesfaye, Solomon [1 ]
机构
[1] Sheffield Teaching Hosp NHS Fdn Trust, Diabet Res Unit, Sheffield, England
[2] Imperial Coll London, Hammersmith Hosp, Peripheral Neuropathy Unit, London, England
[3] Univ Sheffield, Acad Unit Radiol, Sheffield, England
来源
FRONTIERS IN PAIN RESEARCH | 2021年 / 2卷
关键词
pain; biomarkers; skin; vascular; painful diabetic neuropathy; von Willebrand Factor; IENFD; type; 2; diabetes; VON-WILLEBRAND-FACTOR; GROWTH-FACTOR; POLYNEUROPATHY; DYSFUNCTION; REGENERATION; NOCICEPTION; MECHANISMS; ALLODYNIA; PHENOTYPE; DIAGNOSIS;
D O I
10.3389/fpain.2021.731658
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Painful diabetic peripheral neuropathy can be intractable with a major impact, yet the underlying pain mechanisms remain uncertain. A range of neuronal and vascular biomarkers was investigated in painful diabetic peripheral neuropathy (painful-DPN) and painless-DPN and used to differentiate painful-DPN from painless-DPN. Skin biopsies were collected from 61 patients with type 2 diabetes (T2D), and 19 healthy volunteers (HV). All subjects underwent detailed clinical and neurophysiological assessments. Based on the neuropathy composite score of the lower limbs [NIS(LL)] plus seven tests, the T2D subjects were subsequently divided into three groups: painful-DPN (n = 23), painless-DPN (n = 19), and No-DPN (n = 19). All subjects underwent punch skin biopsy, and immunohistochemistry used to quantify total intraepidermal nerve fibers (IENF) with protein gene product 9.5 (PGP9.5), regenerating nerve fibers with growth-associated protein 43 (GAP43), peptidergic nerve fibers with calcitonin gene-related peptide (CGRP), and blood vessels with von Willebrand Factor (vWF). The results showed that IENF density was severely decreased (p < 0.001) in both DPN groups, with no differences for PGP9.5, GAP43, CGRP, or GAP43/PGP9.5 ratios. There was a significant increase in blood vessel (vWF) density in painless-DPN and No-DPN groups compared to the HV group, but this was markedly greater in the painful-DPN group, and significantly higher than in the painless-DPN group (p < 0.0001). The ratio of sub-epidermal nerve fiber (SENF) density of CGRP:vWF showed a significant decrease in painful-DPN vs. painless-DPN (p = 0.014). In patients with T2D with advanced DPN, increased dermal vasculature and its ratio to nociceptors may differentiate painful-DPN from painless-DPN. We hypothesized that hypoxia-induced increase of blood vessels, which secrete algogenic substances including nerve growth factor (NGF), may expose their associated nociceptor fibers to a relative excess of algogens, thus leading to painful-DPN.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Skin Autofluorescence Is Associated with Diabetic Peripheral Neuropathy in Chinese Patients with Type 2 Diabetes: A Cross-Sectional Study
    Wan, Li
    Qin, Guijun
    Yan, Wenhao
    Sun, Tongwen
    GENETIC TESTING AND MOLECULAR BIOMARKERS, 2019, 23 (06) : 387 - 392
  • [22] Acute painful neuropathy restricted to the abdomen following rapid glycaemic control in type 2 diabetes
    Takayama, S
    Takahashi, Y
    Osawa, M
    Iwamoto, Y
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2004, 32 (05) : 558 - 562
  • [23] Painful diabetic neuropathy is associated with increased nerve regeneration in patients with type 2 diabetes undergoing intensive glycemic control
    Ponirakis, Georgios
    Abdul-Ghani, Muhammad A.
    Jayyousi, Amin
    Zirie, Mahmoud A.
    Qazi, Murtaza
    Almuhannadi, Hamad
    Petropoulos, Ioannis N.
    Khan, Adnan
    Gad, Hoda
    Migahid, Osama
    Megahed, Ayman
    Al-Mohannadi, Salma
    AlMarri, Fatema
    Al-Khayat, Fatima
    Mahfoud, Ziyad
    Al Hamad, Hanadi
    Ramadan, Marwan
    DeFronzo, Ralph
    Malik, Rayaz A.
    JOURNAL OF DIABETES INVESTIGATION, 2021, 12 (09) : 1642 - 1650
  • [24] Association of sarcopenia and muscle mass with both peripheral neuropathy and nerve function in patients with type 2 diabetes
    Zhang, Yongze
    Shen, Ximei
    He, Lanlan
    Zhao, Fengying
    Yan, Sunjie
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2020, 162
  • [25] Diabetic Peripheral Neuropathy in Type 2 Diabetes Mellitus in Korea
    Ko, Seung-Hyun
    Cha, Bong-Yun
    DIABETES & METABOLISM JOURNAL, 2012, 36 (01) : 6 - 12
  • [26] Oral dryness and peripheral neuropathy in subjects with type 2 diabetes
    Sandberg, GE
    Wikblad, KF
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2003, 17 (04) : 192 - 198
  • [27] A longitudinal study of sensory biomarkers of progression in patients with diabetic peripheral neuropathy using skin biopsies
    Narayanaswamy, H.
    Facer, P.
    Misra, V. P.
    Timmers, M.
    Byttebier, G.
    Meert, T.
    Anand, P.
    JOURNAL OF CLINICAL NEUROSCIENCE, 2012, 19 (11) : 1490 - 1496
  • [28] Comparison of non-traditional biomarkers, and combinations of biomarkers, for vascular risk prediction in people with type 2 diabetes: The Edinburgh Type 2 Diabetes Study
    Price, Anna H.
    Weir, Christopher J.
    Welsh, Paul
    McLachlan, Stela
    Strachan, Mark W. J.
    Sattar, Naveed
    Price, Jackie F.
    ATHEROSCLEROSIS, 2017, 264 : 67 - 73
  • [29] Effect of aerobic training on nerve conduction in men with type 2 diabetes and peripheral neuropathy: A randomized controlled trial
    Gholami, Farhad
    Nikookheslat, Saeed
    Salekzamani, Yaghoub
    Boule, Normand
    Jafari, Afshar
    NEUROPHYSIOLOGIE CLINIQUE-CLINICAL NEUROPHYSIOLOGY, 2018, 48 (04): : 195 - 202
  • [30] The adjuvant effect of hypertension upon diabetic peripheral neuropathy in experimental Type 2 diabetes
    De Visser, Adriena
    Hemming, Amanda
    Yang, Christina
    Zaver, Shaila
    Dhaliwal, Raj
    Jawed, Zaid
    Toth, Cory
    NEUROBIOLOGY OF DISEASE, 2014, 62 : 18 - 30